Thermo CEO Sheds Light on Sales Strategy for Thermo Fisher; Plans to Refine Pharma Tactics | GenomeWeb

When Thermo Electron and Fisher Scientific close their merger later this year, Fisher's sales force will be able to teach their new colleagues at Thermo a thing or two about building customer relationships, especially at big pharma.

Three days after disclosing plans to merge their companies last Monday (see BioCommerce Week 5/10/2006), Thermo and Fisher's CEOs last week got down to the business of selling the deal to existing and potential investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.